Exelixis
EXEL
#1888
Rank
A$15.39 B
Marketcap
A$60.60
Share price
-1.75%
Change (1 day)
-1.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): A$1.43 Billion

According to Exelixis's latest financial reports the company's current earnings are A$2.32 Billion. , an increase over its 2024 earnings that were of A$0.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 A$1.30 B38.08%
2024 A$0.94 B164.69%
2023 A$0.35 B9.89%
2022 A$0.32 B-20.33%
2021 A$0.40 B124.82%
2020 A$0.18 B-67.14%
2019 A$0.55 B-11.94%
2018 A$0.62 B185.09%
2017 A$0.21 B-325.82%
2016 -A$97.42 Million-58.12%
2015 -A$0.24 Billion-37.61%
2014 -A$0.38 Billion9.75%
2013 -A$0.34 Billion65.96%
2012 -A$0.21 Billion-291.63%
2011 A$0.10 B-195.59%
2010 -A$0.12 Billion-42.17%
2009 -A$0.2 Billion-18.98%
2008 -A$0.24 Billion-6.99%
2007 -A$0.26 Billion46.3%
2006 -A$0.18 Billion33.25%
2005 -A$0.14 Billion-30.92%
2004 -A$0.2 Billion44.29%
2003 -A$0.14 Billion12.86%
2002 -A$0.12 Billion22.79%
2001 -A$95.23 Million60.14%
2000 -A$59.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.54 B 3,464.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.13 B 982.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.45 B 853.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.68 B 718.02%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$31.10 B 2,282.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.94 B 891.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.72 B 951.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-A$45.17 Million-103.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$40.29 Million-103.09%๐Ÿ‡บ๐Ÿ‡ธ USA